Eye Surgery
Frequency of urgent, emergent vitreoretinal surgical procedures during COVID-19
Editor's Note This multi-center study finds that critical vitreoretinal surgical procedures deemed as urgent or emergency decreased nationwide from March until May 2020, even though the American Academy of Ophthalmology said these procedures should continue during the COVID-19 pandemic. Data were collected from 17 institutions throughout the US. Compared to…
ACS opposes proposed Medicare physician fee schedule
Editor's Note The American College of Surgeons (ACS) on August 4 announced that it is strongly opposed to the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule proposed rule for CY 2021. In the fee schedule, which is set to take place January 1, 2021, Medicare payments will…
Joint Commission issues Quick Safety on disinfection of tonometers, other ophthalmology devices
Editor's Note The Joint Commission on May 21 issued Quick Safety 49: Disinfection of tonometers and other ophthalmology devices. The Joint Commission noted that the American Academy of Ophthalmology has reported that transmission of adenovirus and herpes simplex virus HIV, hepatitis C virus, enterovirus 70, Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus,…
Intervention to reduce low-value preop tests before cataract surgery
Editor's Note Reducing low-value testing before cataract surgery was associated with cost savings for financially capitated healthcare systems, but it was also associated with losses for fee-for-service healthcare systems, which could be a barrier to eliminating low-value care, this study finds. Of 1,054 patients (469 intervention, 585 controls) included in…
FDA: Class I recall of RVO 2.0 Raindrop near vision inlay
Editor's Note The Food & Drug Administration (FDA) on March 5 identified the recall by RVO 2.0, Inc (Aliso Viejo, California) of its Raindrop near vision inlay as Class I, the most serious. All lots of the inlay are being recalled because data from the post-approval study showed an increased…
FDA: Class I recall of CyPass Micro-Stent Systems
Editor's Note The Food & Drug Administration (FDA) on October 24 classified Alcon Research’s recall of its CyPass Micro-Stent Systems as Class I, the most serious. The recall was initiated because of the risk of corneal endothelial cell loss with the system, which is used in conjunction with cataract surgery…
FDA: Safety Communication on Raindrop Near Vision Inlay
Editor's Note The Food & Drug Administration (FDA) on October 23 issued a Safety Communication on the increased risk of corneal haze associated with the Raindrop Near Vision Inlay, which is surgically implanted in the cornea of one eye to improve near vision. The notice is to alert eye care…
FDA: Promise Pharmacy recalls one lot of Prednisolone, Gatifloxacin Ophthalmic Solution
Editor's Note The Food & Drug Administration (FDA) on October 22 announced the recall by Promise Pharmacy (Palm Harbor, Florida) of one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3 mL vials (Lot Number 09042018@2, Exp 12/03/2018). The recall was issued because the product was found to have…
Cataract surgery linked to reduced traffic crashes
Editor's Note In this study, cataract surgery was associated with a patient’s reduced subsequent risk of being in a serious traffic crash as a driver. This analysis of 559,546 patients who had cataract surgery in at least one eye found that the crash rate decreased from 2.36 to 2.14 per…
FDA issues Safety Alert for compounded drugs containing triamcinolone, moxifloxacin
Editor's Note The Food & Drug Administration (FDA) on June 14 issued a Safety Alert for compounded drugs containing triamcinolone and moxifloxacin by Guardian Pharmacy Services (Dallas, Texas). At least 43 patients have reported adverse events after receiving eye injections of the compounded triamcinolone and moxifloxacin drug during cataract surgery.…
Free Daily News
- Infusion pumps deemed high-risk in FDA early alert
- Stem cell researchers tout potential for sickle cell disease cure
- Study: Stem cell therapy restores vision in LSCD patients
- AMSURG launches nationwide campaign to spotlight rising colon cancer rates, urges early screening
- AAAHC seeks stakeholder feedback on revised v44 standards to elevate patient-centered care
- Hospital’s anesthesia reforms slash carbon footprint, expenses
- Study: Shifting imaging to outpatient centers could save billions
- Report: Health system margins shrink as hospital revenue grows
- Study: Cataract surgery increases diabetic retinopathy progression
- FDA announces Class 1 endovascular system, anesthesia system recalls